Abstract
A 56-year-old male with chronic renal failure was admitted to the hospital because of progressive hip pain, appetite loss, general fatigue, and hypercalcemia. Slight pain had developed in the left hip 3 months before the initiation of hemodialysis, which subsequently developed into hyperalgesia. The patient was suspected to have sarcoidosis based on the elevated serum angiotensin-converting enzyme and lysozyme levels, and the ocular finding characterized by punched out chorioretinal scarring, although this could not be confirmed by histological evaluations. There was an abnormal uptake of gallium in the dependent portion of the tumoral calcinosis, which could have suggested either the presence of granulomatous sarcoid tissue within the calcified mass or active calcification associated with an inflammatory reaction. Elevated serum concentrations of 1,25-dihydroxyvitamin D3, which should be implicated in the development of hypercalcemia, promptly decreased after the administration of steroids. Steroid administration subsequently led to a decrease in the serum calcium and relief of the hip pain. This was a rare case of sarcoidosis associated with symptomatic tumoral calcinosis and hypercalcemia. The diagnostic significance of a gallium scan in this case will also be discussed.
Similar content being viewed by others
References
Pecovnik-Balon B, Kramberger S. Tumoral calcinosis in patients on hemodialysis. Am J Nephrol. 1997;17:93–5.
Phanish MK, Kallarackal G, Ravanan R, Lawson TM, Baboolal K. Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a hemodialysis patient: successful treatment using intravenous pamidronate. Nephrol Dial Transplant. 2000;15:1691–3.
Eisenberg B, Tzamaloukas AH, Hartshorne MF, Listrom MB, Arrington ER, Sherrard DJ. Periarticular tumoral calcinosis and hypercalcemia in a hemodialysis patient without hyperparathyroidism: a case report. J Nucl Med. 1990;31:1099–103.
Naito T, Nitta K, Kamita N, Honda K, Yoshida T, Koinuma M, et al. Progressive tumoral calcinosis as the presenting feature of sarcoidosis in a patient on hemodialysis treatment. Nephrol Dial Transplant. 1999;14:2716–9.
Hodnett P, Moore M, Kinsella S, Kelly D, Plant WD, Maher MM. Radiological features of progressive tumoral calcinosis in chronic renal failure. Australas Radiol. 2007;51:B115–8.
Rima A, Cardinal E, Bureau NJ, Aubin B, Brassard P. Calcific shoulder tendinitis: treatment with modified US-guided fine-needle technique. Radiology. 2001;221:455–61.
Hammert WC, Lindsay LR. Tumoral calcinosis-or is it? A case report and review. Hand. 2009;4:119–22.
Rothova A. Ocular involvement in sarcoidosis. Br J Opthalmol. 2000;84:110–6.
Johnson DG, Johnson SM, Harris CC, Piantadosi CA, Blinder RA, Coleman RE. Ga-67 uptake in the lung sarcoidosis. Radiology. 1984;150:551–5.
Soudry G, Connoly LP, Treves ST. Ga-67 imaging of tumoral calcinosis associated with secondary hyperparathyroidism. Clin Nucl Med. 1996;21:68–9.
Israel HL, Goldstein RA. Frequency of disordered calcium metabolism in sarcoidosis. Postgrad Med J. 1970;46:468–70.
Conron M, Young C, Beynon C. Review calcium metabolism in sarcoidosis and its clinical implications. Rheumatology. 2000;39:707–13.
Monkawa T, Yoshida T, Hayashi M, Saruta T. Identification of 25-hydroxyvitamin D3 1a-hydroxylase gene expression in macrophages. Kidney Int. 2000;58:559–68.
Kalantar Zedeh K, Nuemayer HH, Wunsch PH, Luft FC. Hypercalcemia and sarcoidosis in an anephric dialysis patient. Nephrol Dial Transplant. 1994;9:829–31.
Brandi L, Daugaard H, Tvedegaard E. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis. Nephron. 1989;53:194–200.
Baker LRI, Abrams SML, Roe CJ, Faugere MC, Fanti P, Subayti Y, et al. 1, 25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. Kidney Int. 1989;35:661–9.
Gallieni M, Kamimura S, Ahmed A, Bravo E, Delmez J, Slatopolsky E, et al. Kinetics of monocyte 1α-hydroxylase in renal failure. Am J Physiol. 1995;268:F746–53.
Putkonen T, Hannuksela M, Halme H. Calcium and phosphorus metabolism in sarcoidosis. Acta Med Scand. 1965;177:327–35.
Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest. 1996;109:535–9.
Motoyama K, Inaba M, Emoto M, Morii H, Nishizawa Y. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement. Intern Med. 2002;41:449–52.
Crystal RG. Sarcoidosis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison’s principle of internal medicine 13th edn. New York: McGraw-Hill; 1994. p. 1679–84.
Olsen KM, Chew FS. Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics. 2006;26:871–85.
Akimoto T, Saito O, Kotoda A, Nishino K, Umino T, Muto S, et al. A case of recurrent renal failure associated with metabolic alkalosis induced by protracted vomiting. Clin Exp Nephrol. 2006;10:279–83.
Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcemia by increased bone resorption which responds to pamidronate. Clin Endocrinol. 1995;43:531–6.
Fogelman I, Mckillop JH, Cowden EA, Fine A, Boyce B, Boyle IT, et al. Bone scan findings in hypervitaminosis D: case report. J Nucl Med. 1977;18:1205–7.
Ahmed M, Almahfouz A, Alarifi A, Nasser T, Alkahtani N, Dayel FA. Hyperparathyroidism secondary to vitamin D deficiency. Clin Nucl Med. 2003;28:413–5.
Lambrinoudaki L, Christodoulakos G, Botsis D. Bisphosphonate. Ann N Y Acad Sci. 2006;1092:397–402.
Gibbs CJ, Peacock M. Hypercalcemia due to sarcoidosis corrects with bisphosphonate treatment. Postgrad Med J. 1986;62:937–8.
Wenzel C, Bartsch R, Hussian D, Pluschnig U, Locker GJ, Sevelda U, et al. Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome. Support Care Cancer. 2004;12:678–81.
Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, Jagannath S, et al. American society of clinical oncology 2007 Clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2007;25:2464–72.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Horikoshi, R., Akimoto, T., Meguro, D. et al. Tumoral calcinosis associated with hypercalcemia in a patient with chronic renal failure. Clin Exp Nephrol 15, 154–158 (2011). https://doi.org/10.1007/s10157-010-0362-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-010-0362-4